SUPERLUMINAL MEDICINES
LIVE

Serial Number

99365859

Owner

Superluminal Medicines, Inc.

Attorney

Gregory B. Coy

First Use Date

Jul 8, 2025

Filing Date

Aug 29, 2025

Add to watchlist:

No watchlists yet
View on USPTO

SUPERLUMINAL MEDICINES Trademark

Serial Number: 99365859

SUPERLUMINAL MEDICINES is a trademark filed by Superluminal Medicines, Inc. on August 29, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Superluminal Medicines, Inc. (5 trademarks)

200 Berkeley Street, 18th Floor
Boston, MA 02116

Entity Type: 03

Trademark Details

Filing Date

August 29, 2025

Registration Date

Not Registered

First Use Anywhere

July 8, 2025

First Use in Commerce

August 14, 2025

Published for Opposition

February 24, 2026

Goods & Services

pharmaceutical agents modulating high value protein targets such as G protein coupled receptors

development of pharmaceutical preparations and medicines

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 21, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 24, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 24, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 18, 2026 NONP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 2, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 2, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 2, 2026 REAP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 29, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 29, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 29, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 29, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 29, 2026 CNEA
ASSIGNED TO EXAMINER
Jan 21, 2026 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jan 20, 2026 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 20, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Aug 29, 2025 MAFR
NEW APPLICATION ENTERED
Aug 29, 2025 NWAP